⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AZN News
AstraZeneca PLC
Acute Myocardial Infarction Market is Expected to Hit Growth Stride at a CAGR of 13% During the Forecast Period (2026-2036) with New Therapeutic Innovations | DelveInsight
prnewswire.com
NVO
BMY
JNJ
AMGN
REGN
SNY
PFE
AZN
LLY
NVS
Idiopathic Pulmonary Fibrosis Market Dynamics, Opportunity Analysis and Forecast Report 2026-2035: Therapeutic Landscape is Anchored by Two Key Products - Esbriet (Pirfenidone), and Ofev
globenewswire.com
BIIB
AZN
FGEN
Caliway Makes First ECO 2026 Oral Presentation on Preclinical Data of CBL-514 in Combination with GLP-1R-Based Weight-Loss Therapies, Attracting Strong Interest from International Experts and Global Pharmaceutical Companies for Its Systemic Metabolic
prnewswire.com
ABBV
AZN
BMY
LLY
NVO
Decades of Neglect Leaves Millions of People with COPD at Risk--National COPD Leaders Call for Urgent Policy Action USA - English USA - English USA - English
prnewswire.com
AZN
SNY
REGN
GSK
Global Radiopharmaceuticals Market Set for Significant Expansion at a CAGR of ~10% by 2034 with Increasing Adoption of Targeted Radiotherapy | DelveInsight
prnewswire.com
LH
TH
GEHC
EL
AZN
AMGN
PFE
MRK
BMY
REGN
GILD
ABBV
SNY
XRAY
BRKR
BAXFENDY approved in the US as the first and only aldosterone synthase inhibitor treatment for adults with hypertension
businesswire.com
AZN
Next Generation Drug Conjugates Market 2026-2035 - Expansion into Non-Oncology Therapeutic Areas Present Opportunities for the $15.75 Billion Market
globenewswire.com
AZN
PFE
NVS
ALNY
Byondis Establishes Scientific Advisory Board of Recognized Leaders in Oncology Research and ADC Development
globenewswire.com
AMGN
CARG
REGN
MRK
AZN
GILD
BIIB
ALGT
AUTL
FIVE
Sensorion nomme Fred Chereau au poste de Directeur Général
businesswire.com
SENS
AZN
ENHERTU ® (fam-trastuzumab deruxtecan-nxki) approved in the US for two new indications for patients with HER2-positive early breast cancer
businesswire.com
AZN